BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 28632435)

  • 1. Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.
    Schmidt DE; Halmin M; Wikman A; Östlund A; Ågren A
    Scand J Clin Lab Invest; 2017 Oct; 77(6):397-405. PubMed ID: 28632435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of blood clotting characteristics using prothrombin complex concentrate, fibrinogen and FXIII in an albumin based fluid: experimental studies in thromboelastometry.
    Koller T; Kinast N; Castellanos AG; Garcia SP; Iglesias PP; Vintro XL; Arranz JM; Seto NV; García MVM; Moreno-Castaño AB; Aznar-Salatti J; Albaladejo GE; Diaz-Ricart M
    Scand J Trauma Resusc Emerg Med; 2021 Apr; 29(1):57. PubMed ID: 33836790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of different sources of fibrinogen supplementation on clot initiation and stability in a model of dilutional coagulopathy.
    Schäfer N; Driessen A; Bauerfeind U; Fröhlich M; Ofir J; Stürmer EK; Maegele M
    Transfus Med; 2016 Oct; 26(5):373-380. PubMed ID: 27506588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.
    Hanna J; Winstedt D; Schött U
    Scand J Clin Lab Invest; 2013 Oct; 73(7):553-62. PubMed ID: 24004348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution.
    Schramko AA; Kuitunen AH; Suojaranta-Ylinen RT; Niemi TT
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):731-5. PubMed ID: 19239406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of viscoelastic hemostatic assays and conventional coagulation tests in trauma patients receiving fibrinogen concentrate.
    Peng HT; Nascimento B; Tien H; Callum J; Rizoli S; Rhind SG; Beckett A
    Clin Chim Acta; 2019 Aug; 495():253-262. PubMed ID: 31004574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII levels, clot strength, and impact of fibrinogen concentrate in infants undergoing cardiopulmonary bypass: a mechanistic sub-study of the FIBCON trial.
    Siemens K; Hunt BJ; Parmar K; Taylor D; Salih C; Tibby SM
    Br J Anaesth; 2023 Feb; 130(2):175-182. PubMed ID: 36371257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models.
    Nagashima F; Inoue S; Koami H; Miike T; Sakamoto Y; Kai K
    J Trauma Acute Care Surg; 2018 Sep; 85(3):588-597. PubMed ID: 29851904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review.
    Kozek-Langenecker S; Sørensen B; Hess JR; Spahn DR
    Crit Care; 2011; 15(5):R239. PubMed ID: 21999308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEM.
    Winstedt D; Thomas OD; Nilsson F; Olanders K; Schött U
    Scand J Trauma Resusc Emerg Med; 2014 Dec; 22():73. PubMed ID: 25510409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.
    Schöchl H; Nienaber U; Hofer G; Voelckel W; Jambor C; Scharbert G; Kozek-Langenecker S; Solomon C
    Crit Care; 2010; 14(2):R55. PubMed ID: 20374650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.
    Schöchl H; Nienaber U; Maegele M; Hochleitner G; Primavesi F; Steitz B; Arndt C; Hanke A; Voelckel W; Solomon C
    Crit Care; 2011; 15(2):R83. PubMed ID: 21375741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Administration of Fibrinogen and Factor XIII Concentrate Does Not Improve Dilutional Coagulopathy Superiorly Than Sole Fibrinogen Therapy: Results of an In-Vitro Thrombelastographic Study.
    Schneck E; Muelich M; Markmann M; Edinger F; Cooper N; Moeller A; Bein G; Hecker A; Koch C; Sander M; Wolff M
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34065924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma.
    Rumph B; Bolliger D; Narang N; Molinaro RJ; Levy JH; Szlam F; Tanaka KA
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):408-12. PubMed ID: 19819728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.
    Winstedt D; Tynngård N; Olanders K; Schött U
    Scand J Trauma Resusc Emerg Med; 2013 Mar; 21():20. PubMed ID: 23517637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.